Home/Filings/4/0000884905-12-000079
4//SEC Filing

Roberge Raymond P 4

Accession 0000884905-12-000079

CIK 0000884905other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 4:28 PM ET

Size

18.6 KB

Accession

0000884905-12-000079

Insider Transaction Report

Form 4
Period: 2012-11-15
Roberge Raymond P
Senior Vice President
Transactions
  • Sale

    Common Stock

    2012-11-15$105.73/sh10,000$1,057,3004,670.872 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2012-11-1510,00012,500 total
    Exercise: $61.47From: 2008-02-27Exp: 2017-02-27Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2012-11-15$61.47/sh+10,000$614,70014,670.872 total
Holdings
  • Stock Option (right to buy)

    Exercise: $60.92From: 2010-02-24Exp: 2019-02-24Common Stock (27,090 underlying)
    27,090
  • Stock Option (right to buy)

    Exercise: $97.84From: 2012-02-22Exp: 2021-02-22Common Stock (19,790 underlying)
    19,790
  • Common Stock

    (indirect: By 401(k))
    70.062
  • Stock Option (right to buy)

    Exercise: $83.89From: 2009-02-26Exp: 2018-02-26Common Stock (13,700 underlying)
    13,700
  • Stock Option (right to buy)

    Exercise: $76.16From: 2011-02-23Exp: 2020-02-23Common Stock (20,465 underlying)
    20,465
  • Stock Option (right to buy)

    Exercise: $109.68From: 2013-02-28Exp: 2022-02-28Common Stock (21,505 underlying)
    21,505
  • Deferred Stock

    Exercise: $0.00Common Stock (15,346.334 underlying)
    15,346.334
Footnotes (8)
  • [F1]This total includes shares previously acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan and unvested restricted stock units.
  • [F2]The $105.73 price reported is the weighted average sale price. The sale prices ranged from $105.56 to $105.99 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
  • [F3]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
  • [F4]This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
  • [F5]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
  • [F6]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
  • [F7]Conversion to Praxair Common Stock is on a 1-for-1 basis.
  • [F8]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.

Issuer

PRAXAIR INC

CIK 0000884905

Entity typeother

Related Parties

1
  • filerCIK 0001548282

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:28 PM ET
Size
18.6 KB